<DOC>
	<DOCNO>NCT03106532</DOCNO>
	<brief_summary>Evaluation optimal dose efficacy reduction intraocular pressure safety PHP-201 ophthalmic solution patient normal tension glaucoma</brief_summary>
	<brief_title>Evaluation PHP-201 Ophthalmic Solution Patients With Normal Tension Glaucoma</brief_title>
	<detailed_description>Data collection ( electronic case report form ) , Data dictionary ( MedDRA )</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Low Tension Glaucoma</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>19 year old , female male IOP ≤21 mmHg Subject show open angle finding , glaucomatous optic nerve damage visual field defect BCVA ≥+0.2 Subject disease surgery history eligible participate ( acute close angle glaucoma , narrow angle glaucoma , advance glaucomatous loss , ocular trauma , eye surgery laser surgery , unstable angina , myocardial infarction , uncontrolled hypertension diabetes , etc ) Subject ca n't discontinue contact lens Subject ca n't discontinue topical/systemic IOP lower medication</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>